Your browser doesn't support javascript.
loading
The Expanded Endocannabinoid System Contributes to Metabolic and Body Mass Shifts in First-Episode Schizophrenia: A 5-Year Follow-Up Study.
Parksepp, Madis; Haring, Liina; Kilk, Kalle; Koch, Kadri; Uppin, Kärt; Kangro, Raul; Zilmer, Mihkel; Vasar, Eero.
Afiliação
  • Parksepp M; Institute of Clinical Medicine, University of Tartu, 50406 Tartu, Estonia.
  • Haring L; Psychiatry Clinic of Viljandi Hospital, 71024 Viljandi, Estonia.
  • Kilk K; Institute of Clinical Medicine, University of Tartu, 50406 Tartu, Estonia.
  • Koch K; Psychiatry Clinic of Tartu University Hospital, 50406 Tartu, Estonia.
  • Uppin K; Centre of Excellence for Genomics and Translational Medicine, Institute of Biomedicine and Translational Medicine, Univesignallingrsity of Tartu, 50090 Tartu, Estonia.
  • Kangro R; Centre of Excellence for Genomics and Translational Medicine, Institute of Biomedicine and Translational Medicine, Univesignallingrsity of Tartu, 50090 Tartu, Estonia.
  • Zilmer M; Psychiatry Clinic of Tartu University Hospital, 50406 Tartu, Estonia.
  • Vasar E; Psychiatry Clinic of Tartu University Hospital, 50406 Tartu, Estonia.
Biomedicines ; 10(2)2022 Jan 24.
Article em En | MEDLINE | ID: mdl-35203453
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article